These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25084055)

  • 1. Determination of receptor protein binding site specificity and relative binding strength using a time-resolved competition assay.
    Barta P; Volkova M; Dascalu A; Spiegelberg D; Trejtnar F; Andersson K
    J Pharmacol Toxicol Methods; 2014; 70(2):145-51. PubMed ID: 25084055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha.
    Reddy CC; Wells A; Lauffenburger DA
    J Cell Physiol; 1996 Mar; 166(3):512-22. PubMed ID: 8600155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational modeling of an epidermal growth factor receptor single-mutation resistance to cetuximab in colorectal cancer treatment.
    Buch I; Ferruz N; De Fabritiis G
    J Chem Inf Model; 2013 Dec; 53(12):3123-6. PubMed ID: 24219403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for inhibition of the epidermal growth factor receptor by cetuximab.
    Li S; Schmitz KR; Jeffrey PD; Wiltzius JJ; Kussie P; Ferguson KM
    Cancer Cell; 2005 Apr; 7(4):301-11. PubMed ID: 15837620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent increases in circulating TGF-alpha and other EGFR ligands act as pharmacodynamic markers for optimal biological dosing of cetuximab and are tumor independent.
    Mutsaers AJ; Francia G; Man S; Lee CR; Ebos JM; Wu Y; Witte L; Berry S; Moore M; Kerbel RS
    Clin Cancer Res; 2009 Apr; 15(7):2397-405. PubMed ID: 19276250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel anti-EGFR monoclonal antibody inhibiting tumor cell growth by recognizing different epitopes from cetuximab.
    Hong KW; Kim CG; Lee SH; Chang KH; Shin YW; Ryoo KH; Kim SH; Kim YS
    J Biotechnol; 2010 Jan; 145(1):84-91. PubMed ID: 19828124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule.
    Nordberg E; Friedman M; Göstring L; Adams GP; Brismar H; Nilsson FY; Ståhl S; Glimelius B; Carlsson J
    Nucl Med Biol; 2007 Aug; 34(6):609-18. PubMed ID: 17707800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cetuximab induce antibody-dependent cellular cytotoxicity against EGFR-expressing esophageal squamous cell carcinoma.
    Kawaguchi Y; Kono K; Mimura K; Sugai H; Akaike H; Fujii H
    Int J Cancer; 2007 Feb; 120(4):781-7. PubMed ID: 17096332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of chelator type on in vitro receptor binding and stability in 177Lu-labeled cetuximab and panitumumab.
    Novy Z; Laznickova A; Mandikova J; Barta P; Laznicek M; Trejtnar F
    J Labelled Comp Radiopharm; 2014 Jun; 57(7):448-52. PubMed ID: 24889367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential binding and biological activities of epidermal growth factor and transforming growth factor alpha in a human pancreatic cancer cell line.
    Korc M; Chandrasekar B; Shah GN
    Cancer Res; 1991 Dec; 51(23 Pt 1):6243-9. PubMed ID: 1933884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand binding characterization and molecular analysis of distinct epidermal growth factor-urogastrone receptors in cultured smooth muscle and epithelial cells from guinea pig intestine.
    Yang SG; Ahmad S; Wong NC; Hollenberg MD
    Mol Pharmacol; 1994 Aug; 46(2):256-65. PubMed ID: 8078489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of an epidermal growth factor/transforming growth factor alpha tail chimera with the human epidermal growth factor receptor reveals unexpected complexities.
    Puddicombe SM; Wood L; Chamberlin SG; Davies DE
    J Biol Chem; 1996 Nov; 271(48):30392-7. PubMed ID: 8940002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-dependent activation of EGFR in follicular dendritic cells sarcoma is sustained by local production of cognate ligands.
    Vermi W; Giurisato E; Lonardi S; Balzarini P; Rossi E; Medicina D; Bosisio D; Sozzani S; Pellegrini W; Doglioni C; Marchetti A; Rossi G; Pileri S; Facchetti F
    Clin Cancer Res; 2013 Sep; 19(18):5027-38. PubMed ID: 23888072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer.
    Raben D; Helfrich B; Chan DC; Ciardiello F; Zhao L; Franklin W; Barón AE; Zeng C; Johnson TK; Bunn PA
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):795-805. PubMed ID: 15701870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and activity of a humanized monoclonal antibody that selectively neutralizes the epidermal growth factor receptor ligands transforming growth factor-α and epiregulin.
    Beidler CB; Petrovan RJ; Conner EM; Boyles JS; Yang DD; Harlan SM; Chu S; Ellis B; Datta-Mannan A; Johnson RL; Stauber A; Witcher DR; Breyer MD; Heuer JG
    J Pharmacol Exp Ther; 2014 May; 349(2):330-43. PubMed ID: 24518034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keratinocyte growth factor receptor ligands induce transforming growth factor alpha expression and activate the epidermal growth factor receptor signaling pathway in cultured epidermal keratinocytes.
    Dlugosz AA; Cheng C; Denning MF; Dempsey PJ; Coffey RJ; Yuspa SH
    Cell Growth Differ; 1994 Dec; 5(12):1283-92. PubMed ID: 7535082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nimotuzumab and cetuximab block ligand-independent EGF receptor signaling efficiently at different concentrations.
    Berger C; Krengel U; Stang E; Moreno E; Madshus IH
    J Immunother; 2011 Sep; 34(7):550-5. PubMed ID: 21760527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The extracellular domain of the epidermal growth factor receptor. Studies on the affinity and stoichiometry of binding, receptor dimerization and a binding-domain mutant.
    Brown PM; Debanne MT; Grothe S; Bergsma D; Caron M; Kay C; O'Connor-McCourt MD
    Eur J Biochem; 1994 Oct; 225(1):223-33. PubMed ID: 7925442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of ligand-induced site-specific phosphorylation of epidermal growth factor receptor.
    Guo L; Kozlosky CJ; Ericsson LH; Daniel TO; Cerretti DP; Johnson RS
    J Am Soc Mass Spectrom; 2003 Sep; 14(9):1022-31. PubMed ID: 12954170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autocrine ligands for the epidermal growth factor receptor mediate interleukin-8 release from bronchial epithelial cells in response to cigarette smoke.
    Richter A; O'Donnell RA; Powell RM; Sanders MW; Holgate ST; Djukanović R; Davies DE
    Am J Respir Cell Mol Biol; 2002 Jul; 27(1):85-90. PubMed ID: 12091250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.